Cholesterol transporters like Niemann-Pick C1 (NPC1) and the low-density lipoprotein receptor (LDLR) act as viral entry receptors, making them potential therapeutic targets for viral infections [3,4]. The gene discussed is LDLR; the disease is viral infectious disease.